The global eClinical solutions market is expected to grow at a CAGR of ~14% in the next five years. The growing complexity of clinical trials, rising adoption of decentralized clinical trials, a surge ...

In many cases, we’ve simply layered new tools onto an outdated operating model. The structure beneath—the way clinical trials ...

Clinical trials often face low accrual and retention, and involving communities in their planning and conduct is crucial to ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the increasing demand for personalized medicines, expansion in clinical research ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer ...

Phase III clinical trials now average 3.6 million datapoints, a threefold increase over the last decade. 1 The Certara Pinnacle 21 platform is designed to solve the data standardization challenges of ...

In this video interview, Heather Horville, solutions consultant at Greenphire, emphasizes the growing need for clinical operations to embed patient-centric services—from consent through final visit—to ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Racial and ethnic diversity is lacking in PsA clinical trials, with non-White participants remaining severely underrepresented.